A new class of medications, particularly GLP-1 drugs, is transforming consumer behavior regarding food. These drugs adjust hunger signals and facilitate smaller portions with greater nutritional value. As people demand more from less food, protein is becoming a focal point in various unexpected food products. This shift challenges traditional notions of indulgence versus nutrition, creating an environment where healthy eating can still deliver pleasure. The evolution of snack options reflects this desire for satiety and optimization, redefining how protein is perceived and utilized in diets.
GLP-1 drugs like Ozempic and Wegovy are altering hunger signals in the brain, reshaping consumption patterns and redefining how we think about food.
We're entering a phase where people are eating less but expecting more from what they do eat, which is why protein is showing up in unexpected places.
Collection
[
|
...
]